Ibuprofen reduces chances of developing acute mountain sickness

USA Today reports, “The American College of Emergency Physicians released a study of hikers who took ibuprofen before, during and after an ascent to high altitude.” The chances “of developing acute mountain sickness, or AMS, were far more likely in a placebo group than in those who took ibuprofen.”

HealthDay reports, “Among the participants who developed altitude sickness, those who took ibuprofen had less severe symptoms than those who took the placebo, though it was not statistically significant.”

The research “appears in the Annals of Emergency Medicine.”

The CNN “The Chart” blog points out that “the prospect of using an over-the-counter pain reliever to stave off altitude sickness is appealing, the researchers say, because the only two drugs currently approved to prevent and treat the condition, acetazolamide and dexamethasone, are prescription-only and carry a risk of side effects.”

This entry was posted in General Health. Bookmark the permalink.